Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
XENE
XENE News & Events
-
Add to Watchlist
Trade XENE
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
XENE News
Driehaus Capital Increases Stake in Xenon Pharmaceuticals
Mar 13 2026
Fool
Xenon Pharmaceuticals Prices $650 Million Upsized Public Offering
Mar 11 2026
NASDAQ.COM
Xenon Pharmaceuticals Upsizes Public Offering to $650 Million
Mar 11 2026
seekingalpha
Wall Street Analysts Adjust Ratings
Mar 10 2026
Benzinga
Xenon Pharmaceuticals Stock Surpasses Analyst Target Price
Mar 10 2026
NASDAQ.COM
Xenon Plans New Drug Application Submission
Mar 10 2026
stocktwits
Xenon and Relmada Surge on Positive Drug Data
Mar 09 2026
Yahoo Finance
Xenon Pharmaceuticals Launches $500 Million Public Offering
Mar 09 2026
seekingalpha
Show More News
XENE Events
03/11 06:00
Deal Size Increased to $650M in Common Stock
The deal size was increased to $650M in common stock from $500M in common stock. JPMorgan, Jefferies, TD Cowen, Stifel, RBC Capital and William Blair acted as joint book running managers for the offering.
Show More Events
XENE Monitor News
Xenon Pharmaceuticals to Announce Phase 3 Data for Azetukalner
Mar 09 2026
XENE Earnings Analysis
No Data
People Also Watch
